HER-2 Protein Overexpression trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All HER-2 Protein Overexpression trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
  NCT06695845 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago Ridge
• PRE-ISPY Phase I/II Oncology Platform Program
  NCT05868226 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago, New Lenox, Orland Park